| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma | 38 | 2021 | 321 | 9.890 |
Why?
|
| Retina | 45 | 2022 | 2661 | 5.250 |
Why?
|
| Retinal Neoplasms | 20 | 2016 | 151 | 5.080 |
Why?
|
| Retinoblastoma Protein | 20 | 2021 | 673 | 3.220 |
Why?
|
| Neuroblastoma | 16 | 2022 | 1266 | 3.150 |
Why?
|
| Stem Cells | 22 | 2022 | 3540 | 1.850 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 9 | 2016 | 362 | 1.420 |
Why?
|
| Gene Expression Regulation, Developmental | 17 | 2022 | 3613 | 1.320 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 2020 | 306 | 1.310 |
Why?
|
| Nuclear Proteins | 19 | 2018 | 5803 | 1.300 |
Why?
|
| Xenograft Model Antitumor Assays | 14 | 2020 | 3621 | 1.220 |
Why?
|
| Cell Differentiation | 29 | 2022 | 11684 | 1.150 |
Why?
|
| Rhabdomyosarcoma | 5 | 2022 | 358 | 1.140 |
Why?
|
| Retinal Rod Photoreceptor Cells | 6 | 2019 | 204 | 1.120 |
Why?
|
| Disease Models, Animal | 24 | 2020 | 18366 | 0.940 |
Why?
|
| DNA Helicases | 6 | 2016 | 854 | 0.920 |
Why?
|
| Retinal Bipolar Cells | 3 | 2020 | 46 | 0.900 |
Why?
|
| Organoids | 2 | 2021 | 745 | 0.870 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2022 | 99 | 0.850 |
Why?
|
| Killer Cells, Natural | 4 | 2020 | 2211 | 0.830 |
Why?
|
| Osteosarcoma | 6 | 2019 | 911 | 0.830 |
Why?
|
| Mice | 74 | 2022 | 82074 | 0.790 |
Why?
|
| Genes, Retinoblastoma | 5 | 2015 | 125 | 0.780 |
Why?
|
| Epigenesis, Genetic | 11 | 2021 | 3836 | 0.770 |
Why?
|
| Neurogenesis | 3 | 2022 | 865 | 0.760 |
Why?
|
| Animals | 97 | 2022 | 169408 | 0.750 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2022 | 792 | 0.740 |
Why?
|
| Gangliosides | 2 | 2019 | 132 | 0.720 |
Why?
|
| Tumor Suppressor Protein p53 | 14 | 2016 | 2960 | 0.710 |
Why?
|
| Epigenomics | 6 | 2022 | 961 | 0.700 |
Why?
|
| Cell Cycle | 12 | 2015 | 2937 | 0.700 |
Why?
|
| Euchromatin | 1 | 2019 | 54 | 0.670 |
Why?
|
| Neoplasms | 18 | 2023 | 22390 | 0.660 |
Why?
|
| Cell Division | 12 | 2007 | 4478 | 0.640 |
Why?
|
| Eye | 5 | 2014 | 712 | 0.630 |
Why?
|
| Interleukin-15 | 1 | 2019 | 186 | 0.620 |
Why?
|
| Retinal Degeneration | 4 | 2022 | 414 | 0.610 |
Why?
|
| Topotecan | 2 | 2010 | 131 | 0.600 |
Why?
|
| Synapses | 5 | 2020 | 1766 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2021 | 8664 | 0.580 |
Why?
|
| Homeodomain Proteins | 8 | 2022 | 2431 | 0.560 |
Why?
|
| Heterochromatin | 1 | 2019 | 294 | 0.550 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2017 | 42 | 0.550 |
Why?
|
| alpha-Thalassemia | 1 | 2017 | 53 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2017 | 4528 | 0.550 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2016 | 1064 | 0.540 |
Why?
|
| Imidazoles | 6 | 2017 | 1169 | 0.540 |
Why?
|
| Cell Proliferation | 15 | 2022 | 10486 | 0.540 |
Why?
|
| Organogenesis | 1 | 2018 | 214 | 0.540 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2015 | 2848 | 0.540 |
Why?
|
| Bone Neoplasms | 6 | 2019 | 2565 | 0.530 |
Why?
|
| Molecular Targeted Therapy | 5 | 2018 | 2830 | 0.530 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2018 | 2433 | 0.520 |
Why?
|
| Laryngeal Neoplasms | 4 | 2021 | 514 | 0.520 |
Why?
|
| Genomics | 12 | 2021 | 5928 | 0.500 |
Why?
|
| Neurons | 10 | 2022 | 9524 | 0.500 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2017 | 633 | 0.500 |
Why?
|
| Cell Line, Tumor | 23 | 2022 | 17174 | 0.500 |
Why?
|
| Antineoplastic Agents | 13 | 2021 | 13699 | 0.500 |
Why?
|
| Genetic Engineering | 4 | 2015 | 936 | 0.490 |
Why?
|
| Histones | 5 | 2019 | 2603 | 0.480 |
Why?
|
| Retinal Ganglion Cells | 4 | 2022 | 811 | 0.480 |
Why?
|
| Cell Cycle Proteins | 12 | 2018 | 3450 | 0.480 |
Why?
|
| Immunotherapy | 4 | 2020 | 4755 | 0.460 |
Why?
|
| Radiosurgery | 4 | 2021 | 1346 | 0.460 |
Why?
|
| Mice, Knockout | 20 | 2022 | 14485 | 0.450 |
Why?
|
| Piperazines | 7 | 2017 | 2553 | 0.450 |
Why?
|
| Mice, Transgenic | 12 | 2022 | 9564 | 0.430 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 288 | 0.430 |
Why?
|
| Cell Lineage | 9 | 2022 | 2576 | 0.420 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 3554 | 0.420 |
Why?
|
| Chromatin | 6 | 2019 | 2981 | 0.410 |
Why?
|
| Cell Death | 7 | 2014 | 1682 | 0.410 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2021 | 812 | 0.410 |
Why?
|
| Retinal Horizontal Cells | 1 | 2011 | 10 | 0.400 |
Why?
|
| Acetates | 2 | 2012 | 317 | 0.390 |
Why?
|
| Oxazines | 1 | 2014 | 358 | 0.390 |
Why?
|
| DNA Methylation | 4 | 2021 | 4432 | 0.390 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2019 | 5707 | 0.380 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 9264 | 0.380 |
Why?
|
| Humans | 126 | 2023 | 768887 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2021 | 1891 | 0.380 |
Why?
|
| Dendrites | 2 | 2011 | 472 | 0.370 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2011 | 94 | 0.370 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 11886 | 0.370 |
Why?
|
| Radiation Oncology | 3 | 2021 | 572 | 0.350 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 521 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2016 | 2892 | 0.350 |
Why?
|
| Body Patterning | 3 | 2015 | 634 | 0.340 |
Why?
|
| Globins | 5 | 1998 | 405 | 0.340 |
Why?
|
| Melphalan | 1 | 2011 | 421 | 0.340 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1966 | 0.340 |
Why?
|
| High-Throughput Screening Assays | 4 | 2018 | 941 | 0.340 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 718 | 0.340 |
Why?
|
| Cebus | 1 | 2009 | 15 | 0.330 |
Why?
|
| Carboplatin | 2 | 2010 | 799 | 0.330 |
Why?
|
| Interneurons | 2 | 2007 | 593 | 0.330 |
Why?
|
| RNA Splicing | 2 | 2022 | 905 | 0.330 |
Why?
|
| Aotidae | 1 | 2009 | 57 | 0.330 |
Why?
|
| Retroviridae | 3 | 2007 | 849 | 0.330 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 3421 | 0.320 |
Why?
|
| Nervous System Neoplasms | 2 | 2011 | 91 | 0.320 |
Why?
|
| Pigmentation | 1 | 2009 | 143 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2911 | 0.310 |
Why?
|
| Transcription Factors | 8 | 2022 | 12174 | 0.310 |
Why?
|
| Ciliary Body | 1 | 2009 | 168 | 0.300 |
Why?
|
| Biological Evolution | 3 | 2016 | 1078 | 0.300 |
Why?
|
| Tissue Culture Techniques | 2 | 2006 | 290 | 0.300 |
Why?
|
| Medical Oncology | 2 | 2020 | 2350 | 0.300 |
Why?
|
| Galantamine | 1 | 2008 | 33 | 0.300 |
Why?
|
| Child | 29 | 2022 | 80969 | 0.300 |
Why?
|
| Gene Silencing | 3 | 2014 | 1505 | 0.290 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2011 | 618 | 0.290 |
Why?
|
| Laryngectomy | 2 | 2020 | 245 | 0.290 |
Why?
|
| Genes, myc | 2 | 2011 | 391 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 19 | 2022 | 22381 | 0.290 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1780 | 0.290 |
Why?
|
| Retinoblastoma-Like Protein p107 | 4 | 2009 | 71 | 0.280 |
Why?
|
| Pyrazoles | 3 | 2017 | 2029 | 0.280 |
Why?
|
| Interferon-beta | 1 | 2009 | 349 | 0.280 |
Why?
|
| Gene Amplification | 4 | 2020 | 1099 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 5 | 2008 | 317 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2009 | 2813 | 0.270 |
Why?
|
| Neural Crest | 2 | 2022 | 278 | 0.260 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2008 | 241 | 0.260 |
Why?
|
| Optic Nerve | 1 | 2009 | 571 | 0.260 |
Why?
|
| Anus Neoplasms | 2 | 2021 | 336 | 0.260 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2001 | 1073 | 0.250 |
Why?
|
| Mutation | 19 | 2021 | 30266 | 0.250 |
Why?
|
| Neuroglia | 2 | 2022 | 960 | 0.240 |
Why?
|
| Cell Nucleus | 6 | 2020 | 2885 | 0.240 |
Why?
|
| DNA Repair | 1 | 2014 | 2054 | 0.240 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2004 | 50 | 0.240 |
Why?
|
| Radiotherapy Dosage | 7 | 2023 | 2920 | 0.240 |
Why?
|
| Combined Modality Therapy | 4 | 2023 | 8559 | 0.240 |
Why?
|
| Genetics | 1 | 2005 | 114 | 0.240 |
Why?
|
| Brachytherapy | 2 | 2023 | 1224 | 0.240 |
Why?
|
| Electroporation | 1 | 2006 | 238 | 0.240 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4919 | 0.230 |
Why?
|
| Cyclins | 3 | 2003 | 606 | 0.230 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12809 | 0.230 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1445 | 0.230 |
Why?
|
| Genetic Vectors | 3 | 2009 | 3414 | 0.230 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1209 | 0.220 |
Why?
|
| Dependovirus | 1 | 2009 | 721 | 0.220 |
Why?
|
| Cell Line | 9 | 2021 | 15603 | 0.220 |
Why?
|
| Biomedical Research | 3 | 2020 | 3463 | 0.220 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1755 | 0.220 |
Why?
|
| Neoplasm Staging | 9 | 2023 | 11262 | 0.210 |
Why?
|
| Age of Onset | 2 | 2012 | 3346 | 0.210 |
Why?
|
| Gene Expression Profiling | 9 | 2022 | 9549 | 0.210 |
Why?
|
| Exons | 2 | 2021 | 2395 | 0.210 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 9213 | 0.210 |
Why?
|
| Pediatrics | 2 | 2015 | 3628 | 0.210 |
Why?
|
| Camptothecin | 2 | 2017 | 600 | 0.200 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 73 | 0.200 |
Why?
|
| Pyridines | 1 | 2014 | 2896 | 0.200 |
Why?
|
| Eye Proteins | 6 | 2014 | 628 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1369 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 4 | 2003 | 43 | 0.190 |
Why?
|
| Female | 44 | 2023 | 397464 | 0.190 |
Why?
|
| Interleukin-2 | 2 | 2019 | 1895 | 0.190 |
Why?
|
| Melanoma | 3 | 2015 | 5709 | 0.190 |
Why?
|
| Indoles | 2 | 2021 | 1836 | 0.190 |
Why?
|
| Apoptosis | 4 | 2015 | 9528 | 0.190 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2021 | 121 | 0.180 |
Why?
|
| Mice, Nude | 5 | 2021 | 3631 | 0.180 |
Why?
|
| Species Specificity | 3 | 2013 | 2419 | 0.180 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1193 | 0.180 |
Why?
|
| DNA Copy Number Variations | 4 | 2021 | 2055 | 0.180 |
Why?
|
| Muscle Development | 1 | 2022 | 258 | 0.170 |
Why?
|
| Mice, Inbred ICR | 4 | 2001 | 363 | 0.170 |
Why?
|
| Vincristine | 2 | 2017 | 1040 | 0.170 |
Why?
|
| Rats | 9 | 2010 | 23847 | 0.170 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 2018 | 0.170 |
Why?
|
| Amacrine Cells | 1 | 2020 | 52 | 0.170 |
Why?
|
| Mice, SCID | 2 | 2018 | 2631 | 0.170 |
Why?
|
| Small Molecule Libraries | 3 | 2019 | 742 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2009 | 8200 | 0.170 |
Why?
|
| Drug Synergism | 3 | 2021 | 1762 | 0.170 |
Why?
|
| Repressor Proteins | 4 | 2019 | 2986 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5801 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6131 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2018 | 1913 | 0.170 |
Why?
|
| Nuclear Lamina | 1 | 2019 | 46 | 0.170 |
Why?
|
| Gliosis | 1 | 2000 | 246 | 0.170 |
Why?
|
| Prisoners | 1 | 2023 | 316 | 0.160 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1667 | 0.160 |
Why?
|
| Vision, Ocular | 1 | 2022 | 458 | 0.160 |
Why?
|
| Glottis | 1 | 2020 | 214 | 0.160 |
Why?
|
| Telomere | 2 | 2017 | 943 | 0.160 |
Why?
|
| Transgenes | 2 | 2015 | 1016 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.150 |
Why?
|
| Morpholines | 1 | 2021 | 584 | 0.150 |
Why?
|
| Genome, Human | 5 | 2021 | 4456 | 0.150 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 2542 | 0.150 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2012 | 385 | 0.150 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 5864 | 0.150 |
Why?
|
| Models, Biological | 6 | 2012 | 9499 | 0.150 |
Why?
|
| Drug Discovery | 2 | 2016 | 1068 | 0.150 |
Why?
|
| Central Nervous System | 1 | 2005 | 1345 | 0.150 |
Why?
|
| High Mobility Group Proteins | 1 | 1998 | 179 | 0.140 |
Why?
|
| Co-Repressor Proteins | 2 | 2017 | 190 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 538 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.140 |
Why?
|
| Pathology, Molecular | 1 | 2020 | 329 | 0.140 |
Why?
|
| Erythroid Precursor Cells | 1 | 1998 | 212 | 0.140 |
Why?
|
| Regenerative Medicine | 2 | 2022 | 311 | 0.140 |
Why?
|
| Embryonic Stem Cells | 2 | 2015 | 1251 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 6 | 2015 | 4784 | 0.140 |
Why?
|
| Pyrimidines | 2 | 2021 | 3050 | 0.140 |
Why?
|
| Glycine | 1 | 2001 | 672 | 0.140 |
Why?
|
| Muscle Neoplasms | 1 | 2018 | 130 | 0.140 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 211 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 16051 | 0.140 |
Why?
|
| Conjunctiva | 2 | 2011 | 475 | 0.140 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 4 | 2023 | 1679 | 0.140 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6320 | 0.140 |
Why?
|
| Disease Progression | 6 | 2014 | 13677 | 0.140 |
Why?
|
| Intraocular Pressure | 2 | 2015 | 1304 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3701 | 0.140 |
Why?
|
| Transcriptional Elongation Factors | 1 | 1998 | 169 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4940 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 10778 | 0.130 |
Why?
|
| Drug Repositioning | 1 | 2018 | 245 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2021 | 6546 | 0.130 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1252 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2015 | 3102 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 778 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2022 | 1600 | 0.130 |
Why?
|
| Tretinoin | 2 | 2018 | 525 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2063 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 892 | 0.130 |
Why?
|
| Adult | 21 | 2021 | 223818 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2003 | 4415 | 0.130 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 7148 | 0.130 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 437 | 0.130 |
Why?
|
| Male | 33 | 2023 | 365249 | 0.130 |
Why?
|
| Microphthalmos | 1 | 2015 | 58 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2001 | 1110 | 0.120 |
Why?
|
| Neural Pathways | 1 | 2006 | 3120 | 0.120 |
Why?
|
| Antipsychotic Agents | 2 | 2008 | 3081 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 4064 | 0.120 |
Why?
|
| E2F3 Transcription Factor | 1 | 2014 | 36 | 0.120 |
Why?
|
| Loss of Heterozygosity | 3 | 2015 | 663 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 859 | 0.120 |
Why?
|
| Pyrimidinones | 1 | 2017 | 386 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2016 | 701 | 0.120 |
Why?
|
| Hepatoblastoma | 1 | 2015 | 90 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2017 | 483 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 2022 | 2001 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2014 | 182 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2001 | 1143 | 0.120 |
Why?
|
| Base Sequence | 11 | 2019 | 12430 | 0.110 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 88 | 0.110 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1839 | 0.110 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 206 | 0.110 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 183 | 0.110 |
Why?
|
| Haplorhini | 2 | 2006 | 524 | 0.110 |
Why?
|
| Survival Rate | 6 | 2021 | 12873 | 0.110 |
Why?
|
| Clone Cells | 1 | 2017 | 1670 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2015 | 411 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2008 | 3985 | 0.110 |
Why?
|
| Embryo, Mammalian | 5 | 2006 | 1676 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 1602 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1748 | 0.110 |
Why?
|
| Neoplasms, Experimental | 2 | 2010 | 1231 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 419 | 0.110 |
Why?
|
| DNA Primers | 2 | 2012 | 2827 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 161 | 0.110 |
Why?
|
| Child, Preschool | 10 | 2021 | 42684 | 0.110 |
Why?
|
| Ribonuclease III | 2 | 2012 | 271 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 11119 | 0.110 |
Why?
|
| Genes, Neoplasm | 1 | 2015 | 371 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2014 | 320 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1887 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
| Cisplatin | 1 | 2019 | 1661 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1973 | 0.100 |
Why?
|
| Gene Expression | 4 | 2015 | 7602 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 1674 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 2709 | 0.100 |
Why?
|
| Karnofsky Performance Status | 1 | 2012 | 167 | 0.100 |
Why?
|
| Pneumocystis | 1 | 1992 | 55 | 0.100 |
Why?
|
| Infant | 8 | 2021 | 36541 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2021 | 1141 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1065 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 763 | 0.100 |
Why?
|
| Mesoderm | 2 | 2014 | 679 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3724 | 0.100 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 13593 | 0.100 |
Why?
|
| Phthalazines | 1 | 2014 | 397 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2149 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 394 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 181 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1982 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2001 | 2059 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2006 | 2695 | 0.100 |
Why?
|
| Dacarbazine | 1 | 2014 | 559 | 0.100 |
Why?
|
| Cranial Irradiation | 1 | 2014 | 395 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2001 | 2858 | 0.090 |
Why?
|
| Ophthalmic Artery | 1 | 2011 | 58 | 0.090 |
Why?
|
| Binding Sites | 3 | 2017 | 6023 | 0.090 |
Why?
|
| Pneumonectomy | 1 | 2018 | 1159 | 0.090 |
Why?
|
| Databases, Factual | 4 | 2021 | 8095 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 524 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 3 | 2001 | 420 | 0.090 |
Why?
|
| Smoking | 1 | 2008 | 9094 | 0.090 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 176 | 0.090 |
Why?
|
| Epitopes | 1 | 2017 | 2529 | 0.090 |
Why?
|
| E2F Transcription Factors | 2 | 2014 | 270 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1752 | 0.090 |
Why?
|
| Pons | 1 | 2012 | 242 | 0.090 |
Why?
|
| Middle Aged | 18 | 2023 | 223740 | 0.090 |
Why?
|
| Cell Count | 2 | 2007 | 1833 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2017 | 2592 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 9618 | 0.090 |
Why?
|
| Schizophrenic Psychology | 2 | 2008 | 1651 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1970 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2009 | 3629 | 0.090 |
Why?
|
| Developmental Biology | 1 | 2011 | 79 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2020 | 65485 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1169 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5434 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2014 | 608 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 690 | 0.080 |
Why?
|
| Brain Stem Neoplasms | 1 | 2012 | 191 | 0.080 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 4123 | 0.080 |
Why?
|
| Hospitals | 1 | 2023 | 3903 | 0.080 |
Why?
|
| Aged | 14 | 2021 | 171790 | 0.080 |
Why?
|
| Catheters | 2 | 2023 | 427 | 0.080 |
Why?
|
| Telomerase | 1 | 2014 | 753 | 0.080 |
Why?
|
| Solubility | 1 | 2011 | 1087 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2014 | 864 | 0.080 |
Why?
|
| Protein Binding | 7 | 2017 | 9344 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2008 | 6987 | 0.080 |
Why?
|
| Cell Survival | 2 | 2012 | 5794 | 0.080 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 4926 | 0.080 |
Why?
|
| MicroRNAs | 3 | 2014 | 3811 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 2395 | 0.080 |
Why?
|
| Tubulin | 1 | 1992 | 695 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23652 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2012 | 573 | 0.070 |
Why?
|
| Students, Medical | 1 | 2021 | 1964 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4651 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2009 | 231 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1794 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2017 | 719 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 4077 | 0.070 |
Why?
|
| Transfection | 2 | 2014 | 5763 | 0.070 |
Why?
|
| Prognosis | 6 | 2016 | 30044 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2001 | 4148 | 0.070 |
Why?
|
| Time Factors | 5 | 2019 | 40266 | 0.070 |
Why?
|
| Genotype | 2 | 2012 | 13048 | 0.070 |
Why?
|
| Proteins | 2 | 2003 | 6011 | 0.070 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 17629 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39394 | 0.070 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 12563 | 0.070 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2007 | 101 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 810 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2003 | 816 | 0.070 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 427 | 0.070 |
Why?
|
| Mitochondria | 1 | 2020 | 3683 | 0.070 |
Why?
|
| Anterior Chamber | 1 | 2007 | 194 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2460 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2006 | 185 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2916 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2023 | 81892 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2008 | 453 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1629 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 18065 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 2884 | 0.060 |
Why?
|
| Cancer Vaccines | 1 | 2013 | 1042 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 1891 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2724 | 0.060 |
Why?
|
| Chimera | 1 | 2006 | 454 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 1726 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 266 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1903 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1712 | 0.060 |
Why?
|
| Neurites | 1 | 2007 | 390 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 335 | 0.060 |
Why?
|
| Vitreous Body | 1 | 2007 | 400 | 0.060 |
Why?
|
| Choristoma | 1 | 2006 | 205 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21187 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4593 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1642 | 0.060 |
Why?
|
| Gastrula | 2 | 2003 | 83 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 4168 | 0.060 |
Why?
|
| Cadherins | 1 | 2009 | 906 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2020 | 26394 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2059 | 0.060 |
Why?
|
| DNA | 4 | 2015 | 7214 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 302 | 0.060 |
Why?
|
| Sample Size | 1 | 2007 | 848 | 0.060 |
Why?
|
| Etoposide | 1 | 2005 | 639 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4356 | 0.060 |
Why?
|
| Organ Size | 1 | 2009 | 2268 | 0.060 |
Why?
|
| Endoderm | 2 | 2003 | 165 | 0.060 |
Why?
|
| Critical Illness | 1 | 1997 | 2754 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2018 | 5107 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9442 | 0.050 |
Why?
|
| Cell Movement | 1 | 2015 | 5216 | 0.050 |
Why?
|
| Placebos | 1 | 2008 | 1668 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 867 | 0.050 |
Why?
|
| Cyclin D | 1 | 2003 | 72 | 0.050 |
Why?
|
| Disease Management | 1 | 2014 | 2537 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 1997 | 3800 | 0.050 |
Why?
|
| United States | 5 | 2023 | 73180 | 0.050 |
Why?
|
| Computational Biology | 3 | 2021 | 3562 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 612 | 0.050 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2022 | 36 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2019 | 3446 | 0.050 |
Why?
|
| Xenopus | 2 | 2003 | 711 | 0.050 |
Why?
|
| Electroretinography | 1 | 2004 | 524 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22294 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3138 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2021 | 5905 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2007 | 2674 | 0.050 |
Why?
|
| Nicotine | 1 | 2007 | 681 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 8055 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2003 | 289 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2003 | 234 | 0.050 |
Why?
|
| Adolescent | 10 | 2021 | 89247 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 41800 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 14199 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1714 | 0.050 |
Why?
|
| Oncogenes | 1 | 2007 | 1236 | 0.050 |
Why?
|
| Phylogeny | 1 | 2009 | 2843 | 0.050 |
Why?
|
| Genomic Instability | 2 | 2016 | 715 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2009 | 2771 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2021 | 5956 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 905 | 0.050 |
Why?
|
| Retinal Dysplasia | 1 | 2000 | 12 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8758 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2001 | 152 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2021 | 5035 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4480 | 0.050 |
Why?
|
| Nervous System | 1 | 2004 | 547 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2014 | 3591 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1564 | 0.050 |
Why?
|
| Cyclin D3 | 1 | 2000 | 54 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2021 | 248 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2014 | 19023 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2010 | 2714 | 0.040 |
Why?
|
| Macrophages | 1 | 2015 | 5800 | 0.040 |
Why?
|
| Attention | 2 | 2008 | 2425 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11934 | 0.040 |
Why?
|
| Electron Transport | 1 | 2020 | 211 | 0.040 |
Why?
|
| Retinal Artery | 1 | 2000 | 109 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3811 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2021 | 185 | 0.040 |
Why?
|
| Young Adult | 7 | 2021 | 60110 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5834 | 0.040 |
Why?
|
| Parasitology | 1 | 1999 | 28 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 259 | 0.040 |
Why?
|
| Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2005 | 710 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2022 | 309 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 1120 | 0.040 |
Why?
|
| Medulloblastoma | 1 | 2004 | 683 | 0.040 |
Why?
|
| Needles | 1 | 2022 | 461 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1526 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 6512 | 0.040 |
Why?
|
| Guanosine | 1 | 1998 | 43 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 435 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2008 | 6346 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 370 | 0.040 |
Why?
|
| Cell Separation | 1 | 2004 | 1728 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 383 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1470 | 0.040 |
Why?
|
| Blindness | 1 | 2022 | 587 | 0.040 |
Why?
|
| Memory | 1 | 2008 | 2210 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16735 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2181 | 0.040 |
Why?
|
| Cerebellum | 1 | 2005 | 1522 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 1904 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7885 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2019 | 1498 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 1999 | 202 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 84 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2023 | 841 | 0.040 |
Why?
|
| Malaria, Vivax | 1 | 1999 | 166 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 2475 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 59738 | 0.030 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 1997 | 32 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2783 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 664 | 0.030 |
Why?
|
| DNA Damage | 1 | 2006 | 2472 | 0.030 |
Why?
|
| 3' Flanking Region | 1 | 2016 | 14 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2012 | 3525 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2020 | 2560 | 0.030 |
Why?
|
| Ecosystem | 1 | 2021 | 494 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 771 | 0.030 |
Why?
|
| Protein Methyltransferases | 1 | 2016 | 54 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2016 | 3956 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 239 | 0.030 |
Why?
|
| Ohio | 1 | 1997 | 321 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 12093 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2010 | 6289 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1998 | 828 | 0.030 |
Why?
|
| Mentors | 1 | 2021 | 672 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10115 | 0.030 |
Why?
|
| Calibration | 1 | 2018 | 823 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3588 | 0.030 |
Why?
|
| Erythrocytes | 2 | 1996 | 2421 | 0.030 |
Why?
|
| Alphapapillomavirus | 1 | 2018 | 219 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 395 | 0.030 |
Why?
|
| Mitosis | 1 | 2000 | 1181 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1997 | 570 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 20 | 0.030 |
Why?
|
| Semaphorins | 1 | 2015 | 96 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Microscopy | 1 | 2020 | 909 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2014 | 56 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1057 | 0.030 |
Why?
|
| Larynx | 1 | 2019 | 492 | 0.030 |
Why?
|
| Kinetics | 2 | 2020 | 6334 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2014 | 143 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 577 | 0.030 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2014 | 67 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2015 | 271 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2533 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 507 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 2941 | 0.030 |
Why?
|
| Pliability | 1 | 2012 | 58 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 1997 | 406 | 0.030 |
Why?
|
| Buffers | 1 | 2012 | 143 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 662 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1891 | 0.030 |
Why?
|
| Nevus, Pigmented | 1 | 2014 | 222 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2598 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2041 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1741 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 551 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 17589 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 8765 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 1683 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 859 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 466 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 1876 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 764 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 710 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 13020 | 0.020 |
Why?
|
| Malaria, Falciparum | 1 | 1999 | 1075 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2000 | 1299 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1992 | 275 | 0.020 |
Why?
|
| Propensity Score | 1 | 2019 | 1968 | 0.020 |
Why?
|
| COS Cells | 2 | 2003 | 1135 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 968 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 542 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 7609 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13427 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3056 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2010 | 2299 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 580 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3845 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4291 | 0.020 |
Why?
|
| Biological Availability | 1 | 2010 | 392 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1047 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 1999 | 1741 | 0.020 |
Why?
|
| Cognition | 1 | 2007 | 7080 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 7860 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Medicaid | 1 | 2023 | 2843 | 0.020 |
Why?
|
| Pregnancy | 3 | 2006 | 30175 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 1222 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 27476 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2015 | 2604 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1379 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7453 | 0.020 |
Why?
|
| Cattle | 2 | 2003 | 3820 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 1752 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1994 | 1376 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 6085 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3433 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2525 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2835 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5404 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6856 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3782 | 0.020 |
Why?
|
| Leukemia | 1 | 1994 | 1520 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 1997 | 3608 | 0.020 |
Why?
|
| Conserved Sequence | 2 | 2002 | 1162 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 2235 | 0.020 |
Why?
|
| Alleles | 2 | 2007 | 6901 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1339 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2010 | 1191 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 2 | 2007 | 1356 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 716 | 0.010 |
Why?
|
| Proteomics | 1 | 2018 | 3913 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2007 | 665 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2020 | 54950 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18454 | 0.010 |
Why?
|
| Haplotypes | 1 | 2009 | 2725 | 0.010 |
Why?
|
| Bronchi | 1 | 2007 | 850 | 0.010 |
Why?
|
| Length of Stay | 1 | 1997 | 6525 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3348 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 4042 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 4576 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3951 | 0.010 |
Why?
|
| Yeasts | 1 | 2003 | 279 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 10097 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 463 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.010 |
Why?
|
| Homozygote | 1 | 2006 | 1779 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2006 | 703 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 2108 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 14795 | 0.010 |
Why?
|
| Fetal Development | 1 | 2006 | 771 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2002 | 975 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 306 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4353 | 0.010 |
Why?
|
| Chromatography | 1 | 1999 | 189 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 930 | 0.010 |
Why?
|
| Indonesia | 1 | 1999 | 131 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1895 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6242 | 0.010 |
Why?
|
| Liver | 1 | 1994 | 7579 | 0.010 |
Why?
|
| Naphthol AS D Esterase | 1 | 1997 | 14 | 0.010 |
Why?
|
| Risk Factors | 2 | 2018 | 74971 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 6031 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 1143 | 0.010 |
Why?
|
| Developing Countries | 1 | 2008 | 2906 | 0.010 |
Why?
|
| Immunoassay | 1 | 1999 | 746 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 36861 | 0.010 |
Why?
|
| Quality of Life | 1 | 1997 | 13510 | 0.010 |
Why?
|
| Intestines | 1 | 2003 | 1911 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1997 | 921 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1997 | 693 | 0.010 |
Why?
|
| Peroxidase | 1 | 1997 | 610 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 777 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12469 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 1993 | 373 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 1866 | 0.010 |
Why?
|
| Primates | 1 | 1994 | 522 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1994 | 716 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 15875 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1993 | 693 | 0.010 |
Why?
|
| Rabbits | 1 | 1994 | 4774 | 0.000 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1560 | 0.000 |
Why?
|
| Acute Disease | 1 | 1997 | 7245 | 0.000 |
Why?
|